drugset
drugset / Trial / NCT02785159

Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis

NCT02785159 ↗

Phase 2 Completed 152 enrolled Bausch Health Americas, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis

Timeline

Start
2016-02
Primary completion
2016-11-20
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject IDP-118 Unknown — —
Comparator Tazarotene Small molecule — —

Indications

psoriasis